PERIO-02: Phase 1b pressure enabled regional immuno-oncology trial of nelitolimod (SD-101), a class C TLR9 agonist, delivered via hepatic artery infusion plus /-checkpoint inhibition in intrahepatic cholangiocarcinoma and hepatocellular carcinoma.

被引：0

作者：

Lee, Sunyoung S.

Almhanna, Khaldoun

Sheth, Rahul

Pant, Shubham

Kuban, Joshua

Maxwell, Aaron Wilhelm Palmer

Witt, Brian Justin

LaPorte, Jason

Hulstine, Ann-Marie

Cox, Bryan

Carvajal, Richard D.

White, Ruth Aroon

Weintraub, Joshua

Davis, Lindsey

Hart, James

Knight, Robert D.

Katz, Steven C.

Javle, Milind M.

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX USA

[2] Brown Univ, Providence, RI USA

[3] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX USA

[5] Univ Texas MD Anderson Canc Ctr, Dept Intervent Radiol, Houston, TX USA

[6] Brown Univ, Warren Alpert Med Sch, Providence, RI USA

[7] TriSalus Life Sci, Westminster, CO USA

[8] TriSalus, Westminster, CO USA

[9] Northwell Hlth Canc Inst, New Hyde Pk, NY USA

[10] Columbia Univ, Med Ctr, New York, NY USA

[11] Columbia Univ, Irving Med Ctr, New York, NY USA

[12] Univ Colorado, Aurora, CO USA

[13] TriSalus Life Sci, Gaithersburg, MD USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2622

引用

页数：1

共 2 条

[1] PERIO-01: Initial safety experience and immunologic effects of a Class C TLR9 agonist using pressure-enabled drug delivery in a phase 1 trial of hepatic arterial infusion of SD-101+/- checkpoint inhibition in metastatic uveal melanoma
Patel, Sapna P.
Haymaker, Cara
Sheth, Rahul A.
Kuban, Joshua D.
Weintraub, Joshua
Wehrenberg-Klee, Eric
Novelli, Paula
Gonsalves, Carin
Adamo, Robert
Honaker, Virgina
Timciuc, Laura
Hennegan, Tarin
Molina, Juan C. Amador
Duose, Dzifa
Cuenta, Edwin R. Parras
Lucci, Anthony
Meas, Salyna
Sarli, Vanessa
Prieto, Victor G.
LaPorte, Jason
Hulstine, Ann-Marie
Moody, Ashley
Cox, Bryan
Geller, David
Davar, Diwakar
Montazeri, Kamaneh
Orloff, Marlana
Katz, Steven C.
Carvajal, Richard
CANCER RESEARCH, 2023, 83 (07)
[2] Safety and early biologic effects of phase 1 PERIO-01 trial of pressure-enabled drug delivery (PEDD) of TLR9 agonist SD-101 and immune checkpoint inhibition (ICI) in uveal melanoma metastatic to the liver (MUM)
Montazeri, Kamaneh
Davar, Diwakar
Haymaker, Cara L.
Sheth, Rahul
Kuban, Joshua
Weintraub, Joshua
Wehrenberg-Klee, Eric
Novelli, Paula M.
Gonsalves, Carin F.
Adamo, Robert D.
Lucci, Anthony
Meas, Salyna
Sarli, Vanessa Nicole
Prieto, Victor Gerardo
Geller, David A.
Orloff, Marlana M.
Carvajal, Richard D.
Patel, Sapna Pradyuman
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)

← 1 →